Related Experiment Video

Updated: Oct 13, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

Hypertension in acromegaly: hereditary hypertensive factor produces hypertension by enhancing IGF-I production

H Ohtsuka1, I Komiya, T Aizawa

  • 1Department of Internal Medicine, Kashiwa City Hospital, Japan.

Endocrine Journal
|December 1, 1995
PubMed

Insights

Hypertension affects 37.5% of acromegaly patients, influenced by genetics, insulin-like growth factor I (IGF-I), and serum sodium. Genetic factors contribute to hypertension via increased sodium and IGF-I levels.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Genetics

Background:

  • Acromegaly, a condition caused by excess growth hormone (GH), is associated with cardiovascular complications, including hypertension.
  • Understanding the specific factors contributing to hypertension in acromegaly is crucial for patient management.

Observation:

  • A retrospective analysis of 64 acromegaly patients revealed a hypertension incidence of 37.5% based on WHO criteria.
  • Blood pressure showed positive correlations with age, insulin-like growth factor I (IGF-I), and serum sodium (Na) levels.

Findings:

  • Hypertensive and normotensive groups differed significantly in IGF-I and Na concentrations.
  • A family history of hypertension was present in 75% of hypertensive acromegaly patients.
  • In patients with a family history, blood pressure correlated with IGF-I and Na; in those without, only age correlated with blood pressure.

Implications:

  • Genetic predisposition appears to contribute to hypertension in acromegaly through elevated Na and enhanced IGF-I production.
  • These findings highlight the complex interplay of genetic, hormonal, and metabolic factors in acromegaly-related hypertension.
  • Further research into targeted interventions based on these factors may improve cardiovascular outcomes in acromegaly patients.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...